Clinical trial
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for…
NCT00495131 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00495131 |
|---|---|
| Title | Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients |
| Official title | Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Genotype 1-infected Patients in Taiwan |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Science and Technology Council, Taiwan |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Drug |
| Interventions | Pegylated interferon alfa-2a plus ribavirin |
| Enrollment | 308 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jul 2, 2007 |
| Last update posted | Sep 10, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: